Keith W.  Pfeil net worth and biography

Keith Pfeil Biography and Net Worth

Keith Pfeil has served as our Senior Vice President and Chief Financial Officer since August 2019. Mr. Pfeil joined Globus as Chief Financial Officer in August 2019 after approximately 16 years at CSS Industries, Inc., a publicly traded consumer products company. At CSS, Mr. Pfeil most recently served as the Executive Vice President and Chief Financial Officer. Prior to that role, Mr. Pfeil served in various financial roles of increasing responsibility with focus areas including audit, business development, controllership, financial planning and analysis, investor relations and treasury. Prior to CSS Industries, Mr. Pfeil worked in the transaction advisory practice of Ernst & Young LLP, and prior to that, he worked in the assurance practices of KPMG LLP and Arthur Andersen LLP. Mr. Pfeil holds an Executive Masters of Business Administration from Saint Joseph’s University and a Bachelor of Science in accounting from Elizabethtown College. Provided by Tagnifi.

What is Keith W. Pfeil's net worth?

The estimated net worth of Keith W. Pfeil is at least $42,183.12 as of July 1st, 2021. Mr. Pfeil owns 833 shares of Globus Medical stock worth more than $42,183 as of April 26th. This net worth approximation does not reflect any other investments that Mr. Pfeil may own. Additionally, Mr. Pfeil receives a salary of $675,890.00 as CFO at Globus Medical. Learn More about Keith W. Pfeil's net worth.

How old is Keith W. Pfeil?

Mr. Pfeil is currently 44 years old. There are 4 older executives and no younger executives at Globus Medical. The oldest executive at Globus Medical is Mr. Daniel T. Scavilla, President, CEO & Director, who is 59 years old. Learn More on Keith W. Pfeil's age.

What is Keith W. Pfeil's salary?

As the CFO of Globus Medical, Inc., Mr. Pfeil earns $675,890.00 per year. There are 2 executives that earn more than Mr. Pfeil. The highest earning executive at Globus Medical is Mr. Daniel T. Scavilla, President, CEO & Director, who commands a salary of $1,370,000.00 per year. Learn More on Keith W. Pfeil's salary.

How do I contact Keith W. Pfeil?

The corporate mailing address for Mr. Pfeil and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on Keith W. Pfeil's contact information.

Has Keith W. Pfeil been buying or selling shares of Globus Medical?

Keith W. Pfeil has not been actively trading shares of Globus Medical during the past quarter. Most recently, Keith W. Pfeil sold 29,167 shares of the business's stock in a transaction on Thursday, February 2nd. The shares were sold at an average price of $77.57, for a transaction totalling $2,262,484.19. Learn More on Keith W. Pfeil's trading history.

Who are Globus Medical's active insiders?

Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Keith Pfeil (CFO), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.

Are insiders buying or selling shares of Globus Medical?

During the last year, insiders at the medical device company sold shares 2 times. They sold a total of 54,040 shares worth more than $3,026,355.10. The most recent insider tranaction occured on March, 15th when Director Leslie V Norwalk sold 10,590 shares worth more than $550,574.10. Insiders at Globus Medical own 24.3% of the company. Learn More about insider trades at Globus Medical.

Information on this page was last updated on 3/15/2024.

Keith W. Pfeil Insider Trading History at Globus Medical

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/2/2023Sell29,167$77.57$2,262,484.19View SEC Filing Icon  
8/19/2021Sell833$76.13$63,416.29View SEC Filing Icon  
8/2/2021Sell833$83.24$69,338.92View SEC Filing Icon  
7/19/2021Sell834$78.25$65,260.50View SEC Filing Icon  
7/1/2021Sell833$77.43$64,499.19833View SEC Filing Icon  
6/25/2021Sell27,479$75.04$2,062,024.1613,312View SEC Filing Icon  
5/5/2021Sell5,021$75.00$376,575.005,021View SEC Filing Icon  
See Full Table

Keith W. Pfeil Buying and Selling Activity at Globus Medical

This chart shows Keith W Pfeil's buying and selling at Globus Medical by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Globus Medical Company Overview

Globus Medical logo
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Read More

Today's Range

Now: $50.64
Low: $50.55
High: $51.07

50 Day Range

MA: $53.06
Low: $50.35
High: $56.43

2 Week Range

Now: $50.64
Low: $43.38
High: $62.88

Volume

325,305 shs

Average Volume

1,113,635 shs

Market Capitalization

$6.86 billion

P/E Ratio

43.28

Dividend Yield

N/A

Beta

1.08